申请人:Merck Sharp & Dohme Ltd.
公开号:US06333336B1
公开(公告)日:2001-12-25
Pyrazolo[4,3-c]pyridin-3-one derivatives substituted at the 2-position by an optionally substituted aryl or heteroaryl moiety, and having pendant substituents at the 7-position and optionally also at the 6-position, are selective ligands for GABAA receptors, particularly having high affinity for the &agr;2 and/or &agr;3 subunit, and are useful in the treatment and/or prevention of disorders of the central nervous system, including anxiety and convulsions.
吡唑并[4,3-c]吡啶-3-酮衍生物在2位被一个可选择取代的芳基或杂环芳基取代,并在7位具有挂链取代基,也可在6位具有可选择的取代基,是GABAA受体的选择性配体,特别具有对α2和/或α3亚基的高亲和力,并且在治疗和/或预防中枢神经系统疾病,包括焦虑和惊厥方面具有用处。